Anti-Müllerian hormone concentrations and parity in fertile women: the model of oocyte donors. Issue 5 (May 2017)

• Record Type: Journal Article
• Authors: Catteau-Jonard, Sophie; Roux, Marie; Dumont, Agathe; Delesalle, Anne-Sophie; Robin, Geoffroy; Dewailly, Didier
• Is Part Of: Reproductive biomedicine online. Volume 34:Issue 5(2017)
• Page Start: 541
• Page End: 545
• Publication Date: 2017-05
• Subjects: Anti-Müllerian hormone -- fertile women -- oocyte donors -- parity -- spontaneous pregnancy; Human reproductive technology -- Periodicals; Human embryo -- Periodicals; Reproduction -- Periodicals; 616.692
• DOI: 10.1016/j.rbmo.2017.02.010
• Languages: English
• ISSNs: 1472-6483

Abstract

Abstract: In France until the end of 2015, oocyte donors must have had at least one child and be aged 18–37 years. This population of fertile women was selected to examine whether serum anti-Müllerian hormone (AMH) concentration could be a reliable correlate of spontaneous pregnancy in women who had proven their fertility before. A cohort of 217 women followed between 2009 and 2015 for oocyte donation at the University Hospital of Lille comprised this retrospective study. In these egg donors, aged 20–37 (median: 32 years), the median serum AMH level was 22 pmol/l (5–95th percentiles: 4.9–61.8). No significant correlation was found between serum AMH level and the number of children or the youngest child's age. Among the 32 women with AMH <10 pmol/l, 9 and 3 were less than 30 and 25 years old, respectively. Six women (2.8%) had undetectable serum AMH, i.e. <3 pmol/l. In conclusion, serum AMH level measured in this fertile female cohort showed too much variability to be a good fertility index. Assessment of serum AMH should only be discussed for patients at risk of ovarian failure.